- $130.12m
- $595.63m
- $267.64m
Annual income statement for Aemetis, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 166 | 212 | 257 | 187 | 268 |
| Cost of Revenue | |||||
| Gross Profit | 11 | 7.94 | -5.54 | 2.02 | -0.58 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 172 | 227 | 339 | 224 | 308 |
| Operating Profit | -6.07 | -14.7 | -82.4 | -37.4 | -40.3 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -37.6 | -47.3 | -107 | -100 | -98.4 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -36.7 | -47.1 | -108 | -46.4 | -87.5 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -36.7 | -47.1 | -108 | -46.4 | -87.5 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -36.7 | -47.1 | -108 | -46.4 | -87.5 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -1.74 | -1.56 | -2.21 | -1.22 | -1.91 |